Detailed Abstract
[E-poster]
[EP107] Laboratory healthcare gap of Hepatitis B care in Yogyakarta, Indonesia
Arum Tri WAHYUNINGSIH*1, Osman SIANIPAR1, Adika Zhulhi ARJANA1, Rhaina KHAIRANI1, Romi Ade SELSATA2, Fadhilah Khairuna LARASATI2, Alfin Herjuno DWIPUTRO2, Intan Susmita RAFSANJANI3, Budi MULYONO1
1Clinical Pathology and Laboratory Medicine, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Indonesia
2Medical Doctor Programme, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Indonesia
3Medical Doctor Programme, Faculty of Medicine, Universitas Islam Indonesia, Indonesia
Introduction : Serological markers of hepatitis B virus infection (HBsAg, anti-HBs, hepatitis B envelope antigen (HBeAg), anti-HBe, and anti-HBc (hepatitis B core) IgM / IgG) was used as the basis for diagnosis and differences in the chronicity of hepatitis B infection. This study aims to explore the laboratory healthcare gap of the patient with hepatitis B infection in our setting and whether laboratory data completeness affects the results.
Methods : This study used retrospective data taken from the Medical Records of hepatitis B patients at Dr. Sardijto Hospital in 2020. The subjects in this study were hepatitis B patients with positive HBsAg. The exclusion criteria were individuals who had co-infection with the hepatotropic virus or HIV. This study was funded by Deputi Bidang Penguatan Riset dan Pengembangan, Kementerian Riset dan Teknologi/Badan Inovasi Nasional
Results : A total of 232 patients were included in the study. All patients underwent HBsAg examination and tested positive, with 65.09% of subjects had HBV DNA examination. HBeAg examination result was only found in 18% of patients. Anti HBc examinations were only found in 2 patients. No subjects were examined for anti-HBs in this study. The proportion of subjects examined for the liver function was still low (<50%), with the most widely checked parameters are AST and ALT while other parameters are very rare.
Conclusions : The utilization of serological tests and hepatic function in hepatitis B patients in Yogyakarta, Indonesia is still low. Intervention and financial support are needed to improve the quality of life of patients with hepatitis B who were treated
Methods : This study used retrospective data taken from the Medical Records of hepatitis B patients at Dr. Sardijto Hospital in 2020. The subjects in this study were hepatitis B patients with positive HBsAg. The exclusion criteria were individuals who had co-infection with the hepatotropic virus or HIV. This study was funded by Deputi Bidang Penguatan Riset dan Pengembangan, Kementerian Riset dan Teknologi/Badan Inovasi Nasional
Results : A total of 232 patients were included in the study. All patients underwent HBsAg examination and tested positive, with 65.09% of subjects had HBV DNA examination. HBeAg examination result was only found in 18% of patients. Anti HBc examinations were only found in 2 patients. No subjects were examined for anti-HBs in this study. The proportion of subjects examined for the liver function was still low (<50%), with the most widely checked parameters are AST and ALT while other parameters are very rare.
Conclusions : The utilization of serological tests and hepatic function in hepatitis B patients in Yogyakarta, Indonesia is still low. Intervention and financial support are needed to improve the quality of life of patients with hepatitis B who were treated
SESSION
E-poster
E-Session 3/25 ~ 3/27 ALL DAY